Gyorffy S, Clarke A J
Department of Microbiology, University of Guelph, Ontario, Canada.
J Bacteriol. 1992 Aug;174(15):5043-50. doi: 10.1128/jb.174.15.5043-5050.1992.
A monoclonal antibody (PmPG5-3) specific for the O-acetylated peptidoglycan of Proteus mirabilis 19 was produced by an NS-1 myeloma cell line and purified from ascites fluid by a combination of ammonium sulfate precipitation and affinity chromatography. The monoclonal antibody (an immunoglobulin M) was characterized by a competition enzyme-linked immunosorbent assay to be equally specific for both insoluble and soluble O-acetylated peptidoglycan but weakly recognized chemically de-O-acetylated P. mirabilis peptidoglycan, the non-O-acetylated peptidoglycans from Escherichia coli and Bacillus subtilis, and the peptidoglycan monosaccharide precursors N-acetylglucosamine and N-acetylmuramic acid dipeptide. The monoclonal antibody did not react with D-alanine or lipopolysaccharide isolated from P. mirabilis. Based on this evidence, the binding epitope on the P. mirabilis peptidoglycan is predicted to be linear and to comprise the glycan backbone, including both the N- and O-acetyl moieties. Monoclonal antibody PmPG5-3 was used to localize the O acetylation of the P. mirabilis peptidoglycan by immunoelectron microscopy. Murein sacculi of P. mirabilis were heavily and randomly labelled with the immunogold, whereas very little labelling and no labelling were observed on the sacculi isolated from de-O-acetylated P. mirabilis and E. coli, respectively. Based on the apparent pattern of immunogold labelling, a physiological role for peptidoglycan O acetylation in P. mirabilis is proposed.
一株NS-1骨髓瘤细胞系产生了一种针对奇异变形杆菌19的O-乙酰化肽聚糖的单克隆抗体(PmPG5-3),并通过硫酸铵沉淀和亲和层析相结合的方法从腹水液中进行了纯化。该单克隆抗体(一种免疫球蛋白M)通过竞争酶联免疫吸附测定法进行表征,结果表明它对不溶性和可溶性O-乙酰化肽聚糖具有同等特异性,但对化学去O-乙酰化的奇异变形杆菌肽聚糖、大肠杆菌和枯草芽孢杆菌的非O-乙酰化肽聚糖以及肽聚糖单糖前体N-乙酰葡糖胺和N-乙酰胞壁酸二肽的识别较弱。该单克隆抗体与从奇异变形杆菌中分离的D-丙氨酸或脂多糖不发生反应。基于这些证据,预计奇异变形杆菌肽聚糖上的结合表位是线性的,并且包含聚糖主链,包括N-和O-乙酰部分。单克隆抗体PmPG5-3被用于通过免疫电子显微镜定位奇异变形杆菌肽聚糖的O-乙酰化。奇异变形杆菌的细胞壁被免疫金大量随机标记,而从去O-乙酰化的奇异变形杆菌和大肠杆菌分离的细胞壁上分别观察到很少的标记和没有标记。基于免疫金标记的明显模式,提出了肽聚糖O-乙酰化在奇异变形杆菌中的生理作用。